-
link to book
- William Briggs
summary
WHAT JUST HAPPENED? The human cost of the emergency response to COVID-19 has far outweighed the benefits. That’s the sobering verdict of a trio of scholars—a biologist, a statistician, and a philosopher— in this comprehensive assessment of the worst panic-induced disaster in history. As the media fanned the flames of panic, government officials and a new elite of scientific experts ignored the established protocols for mitigating a dangerous disease. Instead, they shut down the world economy, closed every school, confined citizens to their homes, and threatened to enforce a regime of extreme social distancing indefinitely. And the American public—amazingly enough—complied without protest. Modestly but relentlessly focused on what we know and don’t know about the coronavirus, Douglas Axe, William M. Briggs, and Jay W. Richards demonstrate in this eye-opening study what real experts can contribute when a pandemic strikes. In the early spring of 2020, the panic of government officials, the hysteria of the media, and the hubris of suddenly powerful scientists produced a worldwide calamity. The Price of Panic is the essential book for understanding what happened and how to avoid repeating our deadly mistakes.
Let's start with the truth!
Support the Broken Science Initiative.
Subscribe today →
recent posts
If you're seeing this page, you are not currently logged into a profile with access to Affiliate Owners / Medical.
At the 2026 Unbreakable Health Retreat in Miami, Emily Kaplan hosted a panel with Bob Kaplan, Professor Thomas Seyfried, and Dr. Derek Lee on what it means to treat cancer as a metabolic disease. They discussed the glucose-ketone index (GKI), nutritional ketosis, and strategies aimed at restricting the fuels cancer cells depend on while considering how metabolic therapy can fit alongside standard cancer treatment.
The conversation also addressed the practical realities patients face when trying to pursue a metabolic approach within the conventional oncology system, including questions about nutrition, repurposed drugs, inherited cancer risk, and how to evaluate different treatment options. Seyfried and Lee connected these clinical questions back to mitochondrial dysfunction, fermentation, and the metabolic vulnerabilities that may offer additional targets for cancer treatment.
An abbreviated version of this discussion is available here, for free.
At the 2026 Unbreakable Health Retreat in Miami, Professor Thomas Seyfried presented the case that cancer is fundamentally a mitochondrial metabolic disease rather than primarily a genetic one. He contrasts the dominant somatic mutation theory with a metabolic model in which impaired mitochondrial respiration drives a shift toward fermentation, dysregulated cell growth, and the mutations commonly associated with cancer.
Citing the work of Otto Warburg and research from his lab at Boston College, Seyfried explains how cancer cells rely heavily on fermentable fuels—particularly glucose and glutamine—and why mitochondrial dysfunction sits upstream of many of the genetic abnormalities seen in tumors. He also discusses reactive oxygen species, altered cellular signaling, and the role of mitochondria in regulating cell growth and behavior.
The presentation then turns to the therapeutic implications of this model. Seyfried explains strategies aimed at placing tumor cells under metabolic stress by restricting the fuels they depend on, including ketogenic metabolic therapy and approaches targeting glucose and glutamine. For Seyfried, the therapeutic target follows directly from the biology: restrict the fuels cancer cells depend on, exploit their metabolic weaknesses, and treat mitochondrial dysfunction as the central feature of the disease.
An abbreviated version of this discussion is available here, for free.
MetFix and BSI Members can view the full 54-minute video.
